Is Lumen Technologies Stock a Buy or Sell After Westerly Capital Dumped 2.7 Million Shares Worth $22.2 Million?

Westerly Capital sold 2,700,000 Lumen shares (~$22.22M using quarterly average), trimming the quarter-end position value by $15.20M and leaving 800,000 shares valued at $6.22M; the stake fell to 1.37% of AUM from 6.7%. Lumen’s fundamentals show pressure: 2025 revenue $12.4B (down from $13.1B), capex rose to $4.4B from $3.2B, and net debt was over $17B; shares were $8.09 as of Feb 17 and down ~12% YTD through Mar 10. The sizable fund selling combined with rising capex, lower revenue and high leverage implies a cautious near-term outlook — monitor upcoming quarters before adding exposure.

Analysis

Westerly’s material trim is best read as a conviction rotation rather than a simple rebalancing — allocators are exiting levered, capex-heavy telecom exposure in favor of faster-turning, higher-margin equipment and semiconductor suppliers. That creates a two-speed market: immediate supply-driven pressure on the incumbent operator’s paper and a durable pull-through opportunity for component, silicon IP, and test-equipment vendors over the next 6–18 months.

Second-order beneficiaries are not just chip and tester names but the vendors that capture recurring service and spare-part revenues during multi-year fiber upgrade programs; expect outsized revenue visibility for firms that sell software, test cycles, or consumable optics. Conversely, credit-sensitive counterparties (debtholders, regional contractors exposed to prepay structures) and legacy consumer broadband vendors face the largest downside if cash generation lags capex.

Near-term tail risks center on refinancing and timing of enterprise AI-driven bandwidth adoption — these are 0–12 month catalysts that will either validate or further punish the asset class. A contrarian outcome worth watching: disciplined asset monetizations (IRUs, wholesale contracts) could materially shorten the path to positive FCF and trigger a multi-year re-rate, but that outcome requires clear margin stabilization over consecutive quarters.

Key Decisions for Investors

• Long MRVL (6–12 months): buy shares or buy 9–12 month calls (delta ~0.40) as a play on silicon pull-through for coherent optics and DCI. Entry on a single-session pullback of 5–10%; target 30–50% upside, stop -15%. Risk: execution/competition in optics silicon and broader semicycle exposure.
• Long VIAV (3–9 months): buy shares or 6–9 month call spreads to capture test/equipment revenue tail from large fiber upgrade programs. Target 25–40% upside with limited time premium; stop -20%. This is lower-beta exposure to the same structural theme.
• Short LUMN (6–12 months) or buy puts instead of naked short: establish a modest sized short (~1–2% portfolio) after a failed bounce or on a spike in implied vol. Target 40–60% downside if refinancing or EBITDA conversion misses; hard stop at 30% loss. Use options to cap tail risk from positive asset-sale headlines.
• Pairs trade (market-neutral): long MRVL / short LUMN (notional ratio roughly 0.6x MRVL per $1 LUMN short) to express conviction in pull-through while hedging beta and macro risk. Time horizon 6–12 months; target asymmetric return if LUMN continues to de-rate while MRVL captures durable revenue. Exit or rebalance on quarter-on-quarter margin inflection in LUMN.